论文部分内容阅读
目的:探讨麒麟丸联合左卡尼汀治疗特发性少弱精子症的效果。方法:将特发性少弱精子症患者按照数学表法随机分为研究组与对照组各50例。对照组给予左卡尼汀口服溶液;研究组给予麒麟丸联合左卡尼汀,观察治疗前、后患者的精子质量。结果:治疗前对照组与研究组精子浓度[(13.12±3.58)×10~6/mL vs(12.34±3.59)×10~6/mL]、a级精子活动率(12.03%±5.21%vs 12.31%±5.43%)、a+b级精子比例(21.11%±5.32%vs 22.56%±4.69%)相比较,组间无统计学差异(P>0.05);治疗后对照组与研究组精子浓度[(14.06±3.61)×10~6/mL vs(19.18±6.19)×10~6/mL]、精子活动率(68.13%±11.35%vs 78.62%±18.37%)、a级精子活动率(16.24%±7.98%vs 24.67%±8.36%)、a+b级精子比例(29.69%±8.15%vs 45.27%±12.53%)相比较,治疗组显著优于对照组(P<0.05)。结论:麒麟丸联合左卡尼汀对改善精子浓度、a级精子活动率、a+b级精子比例有更好的临床疗效。
Objective: To investigate the effect of Kirin Pills combined with L-carnitine in the treatment of idiopathic oligospermia. Methods: Idiopathic asthenospermia patients were randomly divided into study group and control group according to the mathematical table method in 50 cases. The control group was given L-carnitine oral solution. The study group was given Kirin Pills combined with L-carnitine to observe the sperm quality of the patients before and after treatment. Results: The sperm concentration in the control group and the study group [(13.12 ± 3.58) × 10 ~ 6 / mL vs (12.34 ± 3.59) × 10 ~ 6 / mL vs 12.03% ± 5.21% vs 12.31 % ± 5.43%), a + b grade sperm ratio (21.11% ± 5.32% vs 22.56% ± 4.69%). There was no significant difference between the two groups (P> 0.05) (14.06 ± 3.61) × 10 ~ 6 / mL vs (19.18 ± 6.19) × 10 ~ 6 / mL], sperm motility rate (68.13% ± 11.35% vs 78.62% ± 18.37% ± 7.98% vs 24.67% ± 8.36%), and the ratio of a + b sperm (29.69% ± 8.15% vs 45.27% ± 12.53%) was significantly higher in the treatment group than in the control group (P <0.05). Conclusion: Kirin Pills combined with levocarnitine have better clinical effect on improving sperm concentration, a-class sperm motility and a + b sperm proportion.